Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
5.54
+0.54 (10.80%)
Sep 26, 2025, 4:00 PM EDT - Market closed
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $261.68 million as of September 29, 2025. Its market cap has decreased by -69.87% in one year.
Market Cap
261.68M
Enterprise Value
147.52M
1-Year Change
-69.87%
Ranking
Category
Stock Price
$5.54
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $261.68M, a decrease of -51.39%. That is a compound annual growth rate of -13.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 261.68M | -19.44% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | 610.91M | 13.47% |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |